Daniel E Carvajal-Hausdorf
Overview
Explore the profile of Daniel E Carvajal-Hausdorf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araya C, Mino B, Le Cerf P, Gaete F, Armisen R, Carvajal-Hausdorf D
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596311
Breast cancer is the most common cancer among women and a leading cause of cancer-related deaths. PIK3CA gene mutations, which are often present in advanced HR+ breast cancer, can be...
2.
Blandino A, Scherer D, Rounge T, Umu S, Boekstegers F, Ponce C, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35158906
Long noncoding RNAs (lncRNAs) play key roles in cell processes and are good candidates for cancer risk prediction. Few studies have investigated the association between individual genotypes and lncRNA expression....
3.
Altan M, Toki M, Gettinger S, Carvajal-Hausdorf D, Zugazagoitia J, Sinard J, et al.
J Thorac Oncol
. 2019 Mar;
14(6):1102-1108.
PMID: 30851443
Side effects of immune checkpoint inhibitors, termed immune-related adverse events, are relatively common, but immune checkpoint inhibitor-mediated cardiotoxicities are rare; however, they can be serious and potentially fatal. Pericarditis is...
4.
Carvajal-Hausdorf D, Patsenker J, Stanton K, Villarroel-Espindola F, Esch A, Montgomery R, et al.
Clin Cancer Res
. 2019 Feb;
25(10):3054-3062.
PMID: 30796036
Purpose: Imaging mass cytometry (IMC) uses metal-conjugated antibodies to provide multidimensional, objective measurement of protein targets. We used this high-throughput platform to perform an 18-plex assessment of HER2 ICD/ECD, cytotoxic...
5.
Altan M, Kidwell K, Pelekanou V, Carvajal-Hausdorf D, Schalper K, Toki M, et al.
NPJ Breast Cancer
. 2018 Dec;
4:40.
PMID: 30564631
B7-H4 (VTCN1) is a member of the CD28/B7 family of immune co-inhibitory molecules. The relationship of tumor and stromal B7-H4 protein expression with PD-L1, tumor infiltrating lymphocytes (TILs) and its...
6.
Gupta S, Mani N, Carvajal-Hausdorf D, Bossuyt V, Ho K, Weidler J, et al.
Lab Invest
. 2018 Jun;
98(8):1076-1083.
PMID: 29858579
An on-demand, closed RT-qPCR, the GeneXpert (GX) system, has the potential to provide biomarker information in low-resourced settings and elsewhere. We used this system with a research use only version...
7.
Moore L, Wilkinson R, Altan M, Toki M, Carvajal-Hausdorf D, McGuire J, et al.
NPJ Breast Cancer
. 2018 Mar;
4:6.
PMID: 29560416
Neuronal calcium sensor-1 (NCS-1) has been identified as a binding partner of the taxane, paclitaxel. Our previous study showed that overexpression of NCS-1 increased the efficacy of paclitaxel in vitro,...
8.
Carvajal-Hausdorf D, Mani N, Velcheti V, Schalper K, Rimm D
J Immunother Cancer
. 2017 Oct;
5(1):81.
PMID: 29037255
Background: Immunostimulatory therapies targeting immune-suppressive pathways produce durable responses in advanced solid tumors. Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting oxidoreductase that catalyzes the degradation of tryptophan to kynurenine. IDO induces...
9.
Pelekanou V, Carvajal-Hausdorf D, Altan M, Wasserman B, Carvajal-Hausdorf C, Wimberly H, et al.
Breast Cancer Res
. 2017 Sep;
19(1):109.
PMID: 28946899
No abstract available.
10.
Wasserman B, Carvajal-Hausdorf D, Ho K, Wong W, Wu N, Chu V, et al.
Lab Invest
. 2017 Sep;
97(12):1521-1526.
PMID: 28892092
Historically, mRNA measurements have been tested on several commercially available platforms, but none have gained broad acceptance for assessment of HER2. An mRNA measurement, as a continuous value, has the...